Sinusitis Drugs Market by Product, Disease Type, and Geography - Forecast and Analysis 2023-2027
- Published: Nov 2022
- Pages: 167
- SKU: IRTNTR70260
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The sinusitis drugs market is estimated to grow at a CAGR of 6.23% between 2022 and 2027. The size of the market is forecast to increase by USD 801.39 million. The growth of the market depends on several factors, including the rising prevalence of sinusitis, the growing awareness among people about sinusitis treatment, and the increasing mergers and acquisitions. The global sinusitis drugs market is fragmented, with the presence of many large and medium-sized players. The competition in such fragmented markets has become more intense, largely due to the presence of branded and generic drugs. Also, the high prevalence of hypertension and lack of innovative drugs motivate vendors to come up with more efficient novel drugs, which keeps the pipeline for hypertensive drugs strong with multiple late-stage molecules. These late-stage molecules are expected to be launched during the forecast period, which will aid in the market witnessing new entrants.
This report extensively covers market segmentation by product (steroid nasal sprays, antibiotics, decongestants, and other drugs) and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
What will the Size of the Sinusitis Drugs Market be During the Forecast Period?
To learn more about this report, Download the FREE Report Sample
Sinusitis Drugs Market: Key Drivers, Trends, Challenges, and Customer Landscape
The rising prevalence of sinusitis is notably driving the market growth, although factors such as the use of surgical intervention techniques for sinusitis management may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Sinusitis Drugs Market Driver
The rising prevalence of sinusitis is the key factor driving the global sinusitis drugs market growth. Sinus infection is caused due to fluid entrapment in the sinus glands, thus which allows the spread of germs in these glands. According to the Centers for Disease Control and Prevention (CDC), a sinus infection is usually caused by a virus and affects nine out of ten adults and 5-7 out of 10 children in the US. Cases of sinus infection due to bacteria are less common in the US and affect one out of ten adults and 3-5 out of 10 children in the country.
The risk factors for developing sinusitis in the general population include a history of respiratory tract infection, structural problems within the sinus glands, compromised immunity or the consumption of drugs that suppress immunity, and nasal polyps. Furthermore, the risk factors among children include going to daycare centres, using a pacifier, feeding while lying down, and exposure to second-hand smoke. Such factors will drive market growth during the forecast period.
Key Sinusitis Drugs Market Trend
The increasing investments in R&D by major players will fuel the global sinusitis drugs market growth. The market is currently witnessing an emerging trend of increased investments in R&D by major players for developing novel drugs for the treatment of sinusitis. LYR-210 is a clinical-stage product that is designed using novel technologies, such as a transmucosal therapeutic system. This technology enables an implant to deliver the approved steroids into the sinonasal tissues, which are otherwise difficult to reach using traditional therapeutic options. LYR-210 is inserted into the inflamed sinonasal area of patients with chronic rhinosinusitis.
The Phase I study showed that LYR-210 was well-tolerated and safe and had a significant impact in reducing the symptoms associated with chronic rhinosinusitis. Thus, increasing investments, coupled with the emergence of novel drug delivery systems, will ensure the increased volume consumption of sinusitis drugs, which have a positive impact on the market growth during the forecast period.
Key Sinusitis Drugs Market Challenge
The use of surgical intervention techniques for sinusitis management is a major challenge to the global sinusitis drugs market growth. Functional endoscopic sinus surgery is considered the gold standard for treating chronic rhinosinusitis. Several studies have determined the efficacy of this method in improving the overall symptoms associated with the condition. A study conducted by Bunzen DL et al. evaluated the effect of functional endoscopic sinus surgery in reducing the symptoms associated with chronic rhinosinusitis. The study involved 24 patients, among which 11 patients had chronic rhinosinusitis while 13 patients had chronic rhinosinusitis with nasal polyps. All these patients underwent functional endoscopic sinus surgery, and the overall improvement rate was recorded as 54.2%.
Considering the benefits of functional endoscopic sinus surgery, all the patients could advise this surgical intervention to other people with the same condition, and only 13% of the total studied population (n=24) decided not to undergo surgery again. Hence, the high success rate of functional endoscopic sinus surgery in patients with chronic rhinosinusitis is expected to lead a greater number of patients to opt for this procedure for the overall improvement of their condition, which decreases the propensity for sinusitis drugs and hampers the market growth.
Key Sinusitis Drugs Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates?in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Sinusitis Drugs Market Customer Landscape
Who are the Major Sinusitis Drugs Market Vendors?
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market
abbvie.com - The company offers sinusitis drugs such as RINVOQ (upadacitinib). Also, under this segment, the company conducts research and development, manufacturing, commercialization, and sale of innovative medicines and therapies to allocate resources and assess business performance globally to achieve its established long-term strategic goals.
We also have detailed analyses of the market’s competitive landscape and offer information on 15 market vendors, including :
- Alembic Pharmaceuticals Ltd.
- Aurobindo Pharma Ltd.
- Bayer AG
- Bionpharma Inc.
- CHIESI Farmaceutici SpA
- Cipla Ltd.
- Dr. Reddys Laboratories Ltd.
- Fresenius SE & Co. KGaA
- GlaxoSmithKline Plc
- Hikma Pharmaceuticals Plc
- Johnson & Johnson
- Merck & Co. Inc.
- Neopharma Corp.
- Novartis AG
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
What is the Fastest-Growing Segment in the Sinusitis Drugs Market?
The market share growth by the steroid nasal sprays segment will be significant during the forecast period. The high market share of this segment is attributed to the therapeutic efficacy of these drugs in relieving the signs and symptoms of sinusitis. Steroid nasal sprays are used as off-label prescription drugs. They act by reducing swelling and mucus production, thus relieving the symptoms of nasal congestion and improving the drainage of fluid from the sinus. However, these drugs do not provide immediate relief of symptoms and may require multiple administrations to yield the desired outcome. These drugs are often used in combination with nasal wash for better outcomes in patients with sinusitis and other nasal problems. Flonase, NASACORT AQ, Nasonex, Rhinocort, Zetonna, and QNASL are some of the steroid nasal sprays available in the market.
Get a glance at?the market contribution of various segments Request a PDF Sample
The steroid nasal sprays segment showed a gradual increase in market share with USD 848.24 million in 2017 and continued to grow by 2021. When administered at the prescribed dose, steroid nasal sprays are very effective and safe; however, some adverse events have been reported with the use of these drugs, which include nasal dryness and bleeding. These adverse events are likely to impede the growth potential of the market during the forecast period. To eliminate the risk of such events, it is recommended that steroid nasal sprays should be administered toward the sidewalls of the nose rather than toward the nasal septum. Therefore, such factors may decline the use of steroidal nasal sprays, thereby negatively impacting segment growth during the forecast period. Furthermore, our report provides a brief analysis of the historical and forecast market share and their segments along with the reasons for growth from 2017 to 2027.
The growth of this segment is primarily attributed to the increasing adoption of Sinusitis Drugs, which is driven by an increase in the global prevalence of Sinusitis.
Which are the Key Regions for Sinusitis Drugs Market?
For more insights on the market share of various regions Request PDF Sample now!
North America is projected to contribute 40% of market growth by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The market growth in this region is attributed to the increased investments in R&D by large pharmaceutical companies and the presence of a proper regulatory framework for the approval of new drugs in the region. Also, Genentech is also engaged in conducting Phase II clinical trials on XOLAIR (omalizumab) for the treatment of nasal polyps. The successful launch of new drugs for these indications will result in a paradigm shift from small molecules to biologics and also pave the path for other vendors to enter the market, which contributes to market growth.
This report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. The outbreak of COVID-19 led to a slight decline in the demand for sinusitis drugs in North America. The outbreak of COVID-19 adversely affected all countries in North America, especially the US, in 2020. However, it had only a slightly negative impact on the sinusitis drugs market in North America. This is because various non-urgent treatments and clinical visits were either limited or completely halted due to the lockdowns and government guidelines. Thus, the market in North America witnessed a mixed impact in 2020 and Q1 2021 to some extent. However, by the second half of 2020, lockdown-related restrictions were somewhat relaxed in various countries, which allowed people to go outside their homes. Moreover, as pharmaceutical products were brought under essential services, the demand for and supply of sinusitis drugs were not affected much in North America. Like many other pharmaceutical products, sinusitis drugs were made available to the public through both online and offline channels during 2020-2021. Thus, with the availability of sinusitis drugs, the regional market in focus is expected to register growth during the forecast period.
Segment Overview
Our report forecasts revenue growth at global, regional & country levels and analyzes the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by product, disease type, and region.
- Product Outlook (USD Million, 2017 - 2027)
- Steroid nasal sprays
- Antibiotics
- Decongestants
- Other drugs
- Disease Type Outlook (USD Million, 2017 - 2027)
- Acute sinusitis
- Chronic sinusitis
- Sub-acute sinusitis
- Region Outlook (USD Million, 2017 - 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- ROW
- Argentina
- Australia
- Rest of the world
- North America
Parent Market Analysis
The report categorizes the global sinusitis drugs market as a part of the global pharmaceuticals market within the overall healthcare industry. The parent global pharmaceuticals market covers products and companies engaged in research and development (R&D) or production of generic drugs, non-generic drugs, and veterinary drugs. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.
|
Sinusitis Drugs Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
167 |
|
Base year |
2022 |
|
Historical year |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6.23% |
|
Market growth 2023-2027 |
USD 801.39 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
4.96 |
|
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
|
Performing market contribution |
North America at 40% |
|
Key countries |
US, Germany, UK, France, and China |
|
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
|
Key companies profiled |
AbbVie Inc., Alembic Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Bayer AG, Bionpharma Inc., CHIESI Farmaceutici SpA, Cipla Ltd., Dr. Reddys Laboratories Ltd., Fresenius SE & Co. KGaA, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson & Johnson, Merck & Co. Inc., Neopharma Corp., and Novartis AG |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Sinusitis Drugs Market Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the sinusitis drugs market between 2023 and 2027
- Precise estimation of the size of the sinusitis drugs market and its contribution to the parent market.
- Accurate predictions about upcoming trends and changes in consumer behaviour
- Growth of the sinusitis drugs market industry across North America, Europe, Asia, and the Rest of the World (ROW)
- A thorough analysis of the market’s competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of carbon dioxide market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Disease Type
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global sinusitis drugs market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global sinusitis drugs market 2017 - 2021 ($ million)
- 4.2 Product Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
- 4.3 Disease type Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Disease type Segment 2017 - 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
- 6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
- 6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product
- 6.3 Steroid nasal sprays - Market size and forecast 2022-2027
- Exhibit 34: Chart on Steroid nasal sprays - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Steroid nasal sprays - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Steroid nasal sprays - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Steroid nasal sprays - Year-over-year growth 2022-2027 (%)
- 6.4 Antibiotics - Market size and forecast 2022-2027
- Exhibit 38: Chart on Antibiotics - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Antibiotics - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Antibiotics - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Antibiotics - Year-over-year growth 2022-2027 (%)
- 6.5 Decongestants - Market size and forecast 2022-2027
- Exhibit 42: Chart on Decongestants - Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Data Table on Decongestants - Market size and forecast 2022-2027 ($ million)
- Exhibit 44: Chart on Decongestants - Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on Decongestants - Year-over-year growth 2022-2027 (%)
- 6.6 Other drugs - Market size and forecast 2022-2027
- Exhibit 46: Chart on Other drugs - Market size and forecast 2022-2027 ($ million)
- Exhibit 47: Data Table on Other drugs - Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Chart on Other drugs - Year-over-year growth 2022-2027 (%)
- Exhibit 49: Data Table on Other drugs - Year-over-year growth 2022-2027 (%)
- 6.7 Market opportunity by Product
- Exhibit 50: Market opportunity by Product ($ million)
7 Market Segmentation by Disease Type
- 7.1 Market segments
- Exhibit 51: Chart on Disease Type - Market share 2022-2027 (%)
- Exhibit 52: Data Table on Disease Type - Market share 2022-2027 (%)
- 7.2 Comparison by Disease Type
- Exhibit 53: Chart on Comparison by Disease Type
- Exhibit 54: Data Table on Comparison by Disease Type
- 7.3 Acute sinusitis - Market size and forecast 2022-2027
- Exhibit 55: Chart on Acute sinusitis - Market size and forecast 2022-2027 ($ million)
- Exhibit 56: Data Table on Acute sinusitis - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Chart on Acute sinusitis - Year-over-year growth 2022-2027 (%)
- Exhibit 58: Data Table on Acute sinusitis - Year-over-year growth 2022-2027 (%)
- 7.4 Chronic sinusitis - Market size and forecast 2022-2027
- Exhibit 59: Chart on Chronic sinusitis - Market size and forecast 2022-2027 ($ million)
- Exhibit 60: Data Table on Chronic sinusitis - Market size and forecast 2022-2027 ($ million)
- Exhibit 61: Chart on Chronic sinusitis - Year-over-year growth 2022-2027 (%)
- Exhibit 62: Data Table on Chronic sinusitis - Year-over-year growth 2022-2027 (%)
- 7.5 Sub-acute sinusitis - Market size and forecast 2022-2027
- Exhibit 63: Chart on Sub-acute sinusitis - Market size and forecast 2022-2027 ($ million)
- Exhibit 64: Data Table on Sub-acute sinusitis - Market size and forecast 2022-2027 ($ million)
- Exhibit 65: Chart on Sub-acute sinusitis - Year-over-year growth 2022-2027 (%)
- Exhibit 66: Data Table on Sub-acute sinusitis - Year-over-year growth 2022-2027 (%)
- 7.6 Market opportunity by Disease Type
- Exhibit 67: Market opportunity by Disease Type ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 69: Chart on Market share by geography 2022-2027 (%)
- Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 71: Chart on Geographic comparison
- Exhibit 72: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 Germany - Market size and forecast 2022-2027
- Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.9 UK - Market size and forecast 2022-2027
- Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
- 9.10 China - Market size and forecast 2022-2027
- Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.11 France - Market size and forecast 2022-2027
- Exhibit 105: Chart on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 106: Data Table on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 107: Chart on France - Year-over-year growth 2022-2027 (%)
- Exhibit 108: Data Table on France - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 109: Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 110: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 112: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 113: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 114: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 115: Matrix on vendor position and classification
- 12.3 AbbVie Inc.
- Exhibit 116: AbbVie Inc. - Overview
- Exhibit 117: AbbVie Inc. - Product / Service
- Exhibit 118: AbbVie Inc. - Key offerings
- 12.4 Alembic Pharmaceuticals Ltd.
- Exhibit 119: Alembic Pharmaceuticals Ltd. - Overview
- Exhibit 120: Alembic Pharmaceuticals Ltd. - Product / Service
- Exhibit 121: Alembic Pharmaceuticals Ltd. - Key offerings
- 12.5 Bayer AG
- Exhibit 122: Bayer AG - Overview
- Exhibit 123: Bayer AG - Business segments
- Exhibit 124: Bayer AG - Key offerings
- Exhibit 125: Bayer AG - Segment focus
- 12.6 Dr Reddys Laboratories Ltd.
- Exhibit 126: Dr Reddys Laboratories Ltd. - Overview
- Exhibit 127: Dr Reddys Laboratories Ltd. - Business segments
- Exhibit 128: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibit 129: Dr Reddys Laboratories Ltd. - Segment focus
- 12.7 Fresenius SE and Co. KGaA
- Exhibit 130: Fresenius SE and Co. KGaA - Overview
- Exhibit 131: Fresenius SE and Co. KGaA - Business segments
- Exhibit 132: Fresenius SE and Co. KGaA - Key news
- Exhibit 133: Fresenius SE and Co. KGaA - Key offerings
- Exhibit 134: Fresenius SE and Co. KGaA - Segment focus
- 12.8 GlaxoSmithKline Plc
- Exhibit 135: GlaxoSmithKline Plc - Overview
- Exhibit 136: GlaxoSmithKline Plc - Business segments
- Exhibit 137: GlaxoSmithKline Plc - Key offerings
- Exhibit 138: GlaxoSmithKline Plc - Segment focus
- 12.9 Hikma Pharmaceuticals Plc
- Exhibit 139: Hikma Pharmaceuticals Plc - Overview
- Exhibit 140: Hikma Pharmaceuticals Plc - Business segments
- Exhibit 141: Hikma Pharmaceuticals Plc - Key offerings
- Exhibit 142: Hikma Pharmaceuticals Plc - Segment focus
- 12.10 Johnson and Johnson
- Exhibit 143: Johnson and Johnson - Overview
- Exhibit 144: Johnson and Johnson - Business segments
- Exhibit 145: Johnson and Johnson - Key news
- Exhibit 146: Johnson and Johnson - Key offerings
- Exhibit 147: Johnson and Johnson - Segment focus
- 12.11 Merck and Co. Inc.
- Exhibit 148: Merck and Co. Inc. - Overview
- Exhibit 149: Merck and Co. Inc. - Business segments
- Exhibit 150: Merck and Co. Inc. - Key news
- Exhibit 151: Merck and Co. Inc. - Key offerings
- Exhibit 152: Merck and Co. Inc. - Segment focus
- 12.12 Neopharma Corp.
- Exhibit 153: Neopharma Corp. - Overview
- Exhibit 154: Neopharma Corp. - Product / Service
- Exhibit 155: Neopharma Corp. - Key news
- Exhibit 156: Neopharma Corp. - Key offerings
- 12.13 Novartis AG
- Exhibit 157: Novartis AG - Overview
- Exhibit 158: Novartis AG - Business segments
- Exhibit 159: Novartis AG - Key offerings
- Exhibit 160: Novartis AG - Segment focus
- 12.14 Pfizer Inc.
- Exhibit 161: Pfizer Inc. - Overview
- Exhibit 162: Pfizer Inc. - Product / Service
- Exhibit 163: Pfizer Inc. - Key news
- Exhibit 164: Pfizer Inc. - Key offerings
- 12.15 Sanofi SA
- Exhibit 165: Sanofi SA - Overview
- Exhibit 166: Sanofi SA - Business segments
- Exhibit 167: Sanofi SA - Key news
- Exhibit 168: Sanofi SA - Key offerings
- Exhibit 169: Sanofi SA - Segment focus
- 12.16 Sun Pharmaceutical Industries Ltd.
- Exhibit 170: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibit 171: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 172: Sun Pharmaceutical Industries Ltd. - Key offerings
- 12.17 Teva Pharmaceutical Industries Ltd.
- Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 178: Inclusions checklist
- Exhibit 179: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 180: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 181: Research methodology
- Exhibit 182: Validation techniques employed for market sizing
- Exhibit 183: Information sources
- 13.5 List of abbreviations
- Exhibit 184: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Frequently Asked Questions?
- US
- Germany
- UK
- France
- China
- Rising prevalence of sinusitis
- Increasing investments in R and D by major players
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Did you know?
Did you know?
Did you know?
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
